PHK
VRTX icon

Point72 Hong Kong’s Vertex Pharmaceuticals VRTX Stock Holding History

Point72 Hong Kong’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,400
Closed -$3.01M – 1701
2022
Q3 		$3.01M Buy
10,400
+5,700
+121% +$1.64M 0.18% 236
2022
Q2 		$1.32M Buy
+4,700
New +$1.26M 0.09% 452
2022
Q1 		– Sell
-3,100
Closed -$681K – 2402
2021
Q4 		$681K Sell
3,100
-9,900
-76% -$1.93M 0.06% 694
2021
Q3 		$2.36M Sell
13,000
-9,000
-41% -$1.76M 0.18% 385
2021
Q2 		$4.44M Buy
+22,000
New +$4.6M 0.31% 153
2021
Q1 		– Sell
-6,400
Closed -$1.51M – 2275
2020
Q4 		$1.51M Buy
+6,400
New +$1.47M 0.13% 353

Other funds holding VRTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return